May 13, 2015
An online smoking cessation program that offered personalized guidance and support free of charge to smokers worldwide prompted thousands to quit, and should be used as a blueprint for other global health initiatives, according to one of its founders.
April 30, 2015
Dr. Allan Balmain, an internationally known expert in cancer genetics, has been elected a Fellow of The Royal Society, the oldest continuously operating scientific society in the world.
April 29, 2015
The Helen Diller Family Comprehensive Cancer Center of the University of California, San Francisco and Kure It Cancer Research are pleased to announce that Sabine Mueller, M.D., Ph.D., will receive a 2015 HDFCCC-Kure It Cancer Research Grant for Underfunded Cancer Research.
April 24, 2015
On April 15, 2015, more than forty leaders from across the University of California (UC) system joined representatives from the biomedical industry to discuss plans for strengthening UC’s position as a leader in drug, device and diagnostics development.
April 22, 2015
Renowned UC San Francisco pioneers in cancer, biochemistry, medical genetics and pharmaceutical sciences have been elected as members of the American Academy of Arts and Sciences, which recognizes the world’s most accomplished leaders in science, humanities, arts, business and public affairs.
April 20, 2015
Previous HDFCCC director and long-time RAS researcher Frank McCormick will join a group of prominent cancer research and treatment institutions in a new Stand Up To Cancer (SU2C)-American Cancer Society $20 million Dream Team to combat lung cancer.
April 20, 2015
When Rena Pasick joined UCSF in 2002, she brought a key program: the Minority Training Program in Cancer Control Research (MTPCCR) with sites here and at UCLA.
April 16, 2015
Angiogenesis inhibitors—a widely used class of cancer drugs designed to shrink tumors by preventing them from forming new blood vessels—often work in the short term, but usually become ineffective within months.
April 14, 2015
Gov. Jerry Brown is launching a statewide initiative with the University of California, to advance the field of precision medicine. The effort will involve collaborating with other academic and industry partners and starting to build the infrastructure and assemble the resources necessary to further develop the field.
April 2, 2015
Capitalizing on a rare opportunity to thoroughly analyze a tumor from a lung cancer patient who had developed resistance to targeted drug treatment, UC San Francisco scientists identified a biological escape hatch that explains the resistance, and developed a strategy in mice for shutting it down.